Charles Schwab’s Genesco GCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.4M Sell
393,914
-15,313
-4% -$440K ﹤0.01% 2039
2025
Q4
$10.1M Buy
409,227
+76,494
+23% +$2.19M ﹤0.01% 2137
2025
Q3
$9.65M Buy
332,733
+89,341
+37% +$2.46M ﹤0.01% 2136
2025
Q2
$4.79M Buy
243,392
+97,890
+67% +$2.05M ﹤0.01% 2350
2025
Q1
$3.09M Sell
145,502
-12,669
-8% -$441K ﹤0.01% 2469
2024
Q4
$6.76M Sell
158,171
-70,552
-31% -$2.32M ﹤0.01% 2191
2024
Q3
$6.21M Sell
228,723
-67,388
-23% -$1.87M ﹤0.01% 2261
2024
Q2
$7.66M Sell
296,111
-63,497
-18% -$1.66M ﹤0.01% 2162
2024
Q1
$10.1M Buy
359,608
+31,992
+10% +$924K ﹤0.01% 1973
2023
Q4
$11.5M Buy
327,616
+21,686
+7% +$667K ﹤0.01% 1909
2023
Q3
$9.43M Buy
305,930
+38,049
+14% +$1.08M ﹤0.01% 1936
2023
Q2
$6.71M Buy
267,881
+26,031
+11% +$754K ﹤0.01% 2097
2023
Q1
$8.92M Buy
241,850
+11,637
+5% +$510K ﹤0.01% 1926
2022
Q4
$10.6M Sell
230,213
-4,826
-2% -$219K ﹤0.01% 1823
2022
Q3
$9.24M Sell
235,039
-9,064
-4% -$484K ﹤0.01% 1884
2022
Q2
$12.2M Sell
244,103
-6,617
-3% -$397K ﹤0.01% 1731
2022
Q1
$15.9M Sell
250,720
-15,455
-6% -$1.01M ﹤0.01% 1699
2021
Q4
$17.1M Sell
266,175
-36,872
-12% -$2.34M 0.01% 1706
2021
Q3
$17.5M Sell
303,047
-86,936
-22% -$5.17M 0.01% 1685
2021
Q2
$24.8M Sell
389,983
-46,008
-11% -$2.49M 0.01% 1413
2021
Q1
$20.7M Sell
435,991
-19,402
-4% -$834K 0.01% 1503
2020
Q4
$13.7M Buy
455,393
+3,295
+0.7% +$84.2K 0.01% 1666
2020
Q3
$9.74M Buy
452,098
+29,690
+7% +$581K ﹤0.01% 1715
2020
Q2
$9.15M Sell
422,408
-10,551
-2% -$195K ﹤0.01% 1709
2020
Q1
$5.78M Buy
432,959
+51,278
+13% +$1.73M ﹤0.01% 1762
2019
Q4
$18.3M Buy
381,681
+19,940
+6% +$827K 0.01% 1271
2019
Q3
$14.5M Buy
361,741
+14,139
+4% +$546K 0.01% 1360
2019
Q2
$14.7M Sell
347,602
-46,917
-12% -$2.07M 0.01% 1356
2019
Q1
$18M Buy
394,519
+12,373
+3% +$567K 0.01% 1183
2018
Q4
$16.9M Sell
382,146
-24,656
-6% -$1.07M 0.01% 1104
2018
Q3
$19.2M Sell
406,802
-36,960
-8% -$1.61M 0.01% 1170
2018
Q2
$17.6M Buy
443,762
+53,854
+14% +$2.29M 0.01% 1189
2018
Q1
$15.8M Buy
389,908
+38,188
+11% +$1.42M 0.01% 1162
2017
Q4
$11.4M Buy
351,720
+76,588
+28% +$2.11M 0.01% 1378
2017
Q3
$7.32M Buy
275,132
+74,700
+37% +$2.11M 0.01% 1661
2017
Q2
$6.79M Sell
200,432
-11,426
-5% -$510K 0.01% 1624
2017
Q1
$11.7M Buy
211,858
+6,699
+3% +$399K 0.01% 1204
2016
Q4
$12.7M Buy
205,159
+22,225
+12% +$1.36M 0.01% 1085
2016
Q3
$9.96M Buy
182,934
+45,087
+33% +$2.84M 0.01% 1164
2016
Q2
$8.87M Buy
137,847
+3,589
+3% +$237K 0.01% 1166
2016
Q1
$9.7M Buy
134,258
+5,935
+5% +$383K 0.01% 1075
2015
Q4
$7.29M Buy
128,323
+6,264
+5% +$362K 0.01% 1248
2015
Q3
$6.97M Buy
122,059
+5,923
+5% +$368K 0.01% 1230
2015
Q2
$7.67M Buy
116,136
+14,595
+14% +$1M 0.01% 1239
2015
Q1
$7.23M Buy
101,541
+13,161
+15% +$955K 0.01% 1239
2014
Q4
$6.77M Sell
88,380
-869
-1% -$66K 0.01% 1201
2014
Q3
$6.67M Buy
89,249
+1,219
+1% +$97.2K 0.01% 1127
2014
Q2
$7.23M Buy
88,030
+3,156
+4% +$241K 0.01% 1098
2014
Q1
$6.33M Buy
84,874
+5,891
+7% +$428K 0.01% 1141
2013
Q4
$5.77M Buy
78,983
+3,508
+5% +$245K 0.01% 1137
2013
Q3
$5.02M Buy
75,475
+3,631
+5% +$248K 0.01% 1182
2013
Q2
$4.86M Buy
+71,844
New +$4.62M 0.01% 1081

Other funds holding GCO

Charles Schwab's GCO Position: Q1 2026 in Review

Charles Schwab reduced its Genesco (GCO) stake by 3.7% in Q1 2026, selling an estimated $440K and leaving 393,914 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2039.

Charles Schwab first reported a position in GCO in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.8M in Q2 2021. 129 funds tracked by Wall St. Rank hold GCO as of Q1 2026.

  • Charles Schwab held 393,914 shares of Genesco worth $11.4M as of Q1 2026.
  • Charles Schwab sold 15,313 Genesco shares in Q1 2026, an estimated $440K.
  • Genesco made up ﹤0.01% of Charles Schwab's portfolio in Q1 2026, its #2039 holding.
  • Charles Schwab first reported a position in Genesco in Q2 2013 and has held it in 52 quarters since.
  • Charles Schwab's Genesco position peaked at $24.8M in Q2 2021.
  • 129 funds tracked by Wall St. Rank held Genesco as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.